Skip to main content
Shaheen Lakhan, MD, Neurology, Miami, FL, Cambridge Health Alliance

ShaheenEmmanuelLakhanMDPhD, FAAN(He/Him)

Neurology Miami, FL

Pain Medicine

Chief Medical Officer, Click Therapeutics

Dr. Lakhan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Lakhan's full profile

Already have an account?

Summary

  • Shaheen Lakhan, MD, PhD, FAAN, is a physician-scientist with over 15 years of experience in healthcare, academia, and industry focusing on neuroscience research and development. He is board-certified in both neurology and pain medicine, with clinical training from Cleveland Clinic and Massachusetts General Hospital. As an expert in patient-empowering clinical development from drugs to devices, Dr. Lakhan is keen on transforming medicine and democratizing health care through digital therapeutics (Click Therapeutics).

    Previously, Dr. Lakhan served as faculty of leading institutions (Harvard Medical School, Case Western Reserve University), founding department chair and curricular dean (California University of Science and Medicine), institutional review board chair (Arrowhead Regional Medical Center), chief of pain management (Virginia Tech - Carilion Clinic), and executive/leadership positions in biopharma (Sage Therapeutics, Zogenix) and biotech (The Learning Corp, Fern Health). He continues to serve patients as a practicing neurologist and pain specialist (Cambridge Health Alliance) and is an adjunct professor of neuroscience (Virginia Tech).

    In addition to exemplary clinical service, Dr. Lakhan has an extensive research, education, advocacy, and philanthropy portfolio. He has over 100 peer-reviewed publications, books, and book chapters. For founding the Global Neuroscience Initiative Foundation, he was bestowed the Harvard Medical School Dean's Community Service Award. He was also conferred the President's Call to Service Award for Lifetime Achievement by President George W. Bush and The U.S. Congressional Award Gold Medal by Senators Nancy Pelosi and Harry Reid. Further, California Governor Brown and Virginia Governor Northam have appointed him to prestigious boards including the Health Professions Education Foundation awarding more than $200 million towards closing the health equity gap. He was inducted as Fellow of the American Academy of Neurology.
  • Industry Insights: Shaheen Lakhan - DTx East

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, Pain Medicine, 2014 - 2015
  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationResidency, Internal Medicine, 2010 - 2014
  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationResidency, Neurology, 2010 - 2014
  • Technion-Israel Inst of Technology Faculty of Medicine
    Technion-Israel Inst of Technology Faculty of MedicineClass of 2009, MD, Cum Laude

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2022 - 2025
  • NJ State Medical License
    NJ State Medical License 2022 - 2025
  • MI State Medical License
    MI State Medical License 2022 - 2025
  • CO State Medical License
    CO State Medical License 2022 - 2025
  • MA State Medical License
    MA State Medical License 2014 - 2025
  • PA State Medical License
    PA State Medical License 2023 - 2024
  • GA State Medical License
    GA State Medical License 2022 - 2024
  • American Board of Psychiatry and Neurology Neurology
  • American Board of Psychiatry and Neurology Pain Medicine
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Deep Sleep May Mitigate the Impact of Alzheimer’s Pathology
    Deep Sleep May Mitigate the Impact of Alzheimer’s PathologyMay 16th, 2023
  • Click Therapeutics and Boehringer Ingelheim Initiate Pivotal Clinical Trial of Prescription Digital Therapeutics for the Treatment of Negative Symptoms in Schizophrenia
    Click Therapeutics and Boehringer Ingelheim Initiate Pivotal Clinical Trial of Prescription Digital Therapeutics for the Treatment of Negative Symptoms in SchizophreniaMay 4th, 2023
  • Click Therapeutics Initiates Fully Remote Pivotal Trial Using Investigational Prescription Digital Therapeutics to Treat Episodic Migraine
    Click Therapeutics Initiates Fully Remote Pivotal Trial Using Investigational Prescription Digital Therapeutics to Treat Episodic MigraineApril 25th, 2023
  • Join now to see all

Professional Memberships

Other Languages

  • Hebrew, Spanish

Hospital Affiliations